Interventional cardiologists, electrophysiologists ask CMS to clarify policy after unexpected denials

The Society for Cardiovascular Angiography and Interventions (SCAI), American College of Cardiology (ACC) and Heart Rhythm Society (HRS) have asked the U.S. Centers for Medicare and Medicaid Services (CMS) to clarify a key detail related to the national coverage determination (NCD) for percutaneous left atrial appendage closure (LAAC).

According to the LAAC NCD, “a formal shared decision-making interaction with an independent non-interventional physician using an evidence-based decision tool on oral anticoagulation in patients with non-valvular atrial fibrillation prior to LAAC” is required. However, the three groups noted, there is now some confusion regarding what, exactly, is meant by “an independent non-interventional physician.”

The SCAI, ACC and HRS have always believed this refers to “a separate physician (interventional cardiologist or electrophysiologist) that is not implanting the device.” However, Medicare administrative contractors (MACs) have started issuing denials and saying the interaction cannot be done with any interventional cardiologist or electrophysiologist, even if they are not the physician performing the procedure.

“As interventional cardiologists and electrophysiologists often provide general cardiovascular care for patients with atrial fibrillation, a non-implanting interventional cardiologist or electrophysiologist should be allowed to perform the shared decision-making as intended,” the groups wrote in a letter to CMS. “In fact, based on their experience with catheter-based procedures, interventional cardiologists and electrophysiologists probably provide more insightful advice for the shared decision-making process.”

In addition to asking CMS to clarify this detail, the groups also asked that the agency to “provide education to the MACs” to ensure there is more clarity going forward.

The full letter to CMS can be read here. It is signed by HRS President Jodie L. Hurwitz, MD; ACC President B. Hadley Wilson, MD; and SCAI President George D. Dangas, MD, PhD.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.